Mutual of America Capital Management LLC Buys Shares of 2,287 U.S. Physical Therapy, Inc. (NYSE:USPH)

Mutual of America Capital Management LLC bought a new stake in U.S. Physical Therapy, Inc. (NYSE:USPH) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,287 shares of the company’s stock, valued at approximately $203,000.

Several other large investors also recently bought and sold shares of USPH. Venturi Wealth Management LLC boosted its stake in shares of U.S. Physical Therapy by 3,200.0% during the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock valued at $64,000 after acquiring an additional 704 shares during the last quarter. KBC Group NV boosted its stake in shares of U.S. Physical Therapy by 68.6% during the third quarter. KBC Group NV now owns 774 shares of the company’s stock valued at $66,000 after acquiring an additional 315 shares during the last quarter. Pacer Advisors Inc. acquired a new stake in shares of U.S. Physical Therapy during the fourth quarter valued at $113,000. First Horizon Advisors Inc. boosted its stake in shares of U.S. Physical Therapy by 25.1% during the third quarter. First Horizon Advisors Inc. now owns 1,486 shares of the company’s stock valued at $126,000 after acquiring an additional 298 shares during the last quarter. Finally, Sugar Maple Asset Management LLC acquired a new stake in shares of U.S. Physical Therapy during the third quarter valued at $212,000.

Analyst Ratings Changes

USPH has been the topic of a number of analyst reports. Barrington Research decreased their price objective on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating on the stock in a research note on Friday, February 28th. JPMorgan Chase & Co. increased their price objective on U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Tuesday, December 3rd. Citizens Jmp upgraded U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. JMP Securities assumed coverage on U.S. Physical Therapy in a research report on Monday, December 16th. They set an “outperform” rating and a $113.00 target price on the stock. Finally, Bank of America upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and increased their target price for the stock from $100.00 to $115.00 in a research report on Monday, December 16th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, U.S. Physical Therapy currently has a consensus rating of “Moderate Buy” and a consensus target price of $111.50.

U.S. Physical Therapy Stock Performance

U.S. Physical Therapy stock opened at $79.87 on Tuesday. The stock’s 50-day moving average is $87.21 and its 200-day moving average is $87.56. The company has a market cap of $1.21 billion, a price-to-earnings ratio of 84.96, a price-to-earnings-growth ratio of 3.54 and a beta of 1.51. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. U.S. Physical Therapy, Inc. has a 12 month low of $76.18 and a 12 month high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). The firm had revenue of $180.45 million during the quarter, compared to analysts’ expectations of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. Equities analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be issued a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.25%. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.44. The ex-dividend date is Friday, March 14th. U.S. Physical Therapy’s dividend payout ratio (DPR) is 97.83%.

Insider Transactions at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,730 shares of the firm’s stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $82.11, for a total transaction of $142,050.30. Following the sale, the chief operating officer now directly owns 7,168 shares in the company, valued at approximately $588,564.48. This trade represents a 19.44 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.